Els Torreele
Script error: No such module "Draft topics".
Script error: No such module "AfC topic".
Els Torreele is a bioengineer, researcher and spokesperson on medical innovation and access.
Career[edit]
Torreele is a visiting fellow at the Institute for Innovation and Public purpose at University College London. She has worked for more than two decades in the areas of pharmaceutical research and development, global health, human rights, access to medicines, and public policy development for medical innovation for access. She is a bioengineer and earned her PhD in Biomedical Sciences from the Free University Brussels.
She started working with Médecins Sans Frontières (MSF) on pharmaceutical and science policy in 2000. In MSF she led researched and development projects, among others developing a first all-oral treatment for sleeping sickness. In 2003, she left due to become a founding member of the foundation of the Drugs for Neglected Diseases Initiative, a multidisciplinary think tank to improve needs-driven R&D for diseases that primarily affect developing countries.[1]
In March 2017, Torreele returned to MSF as the Executive Director of the Campaign for Access to Essential Medicines.[2] For the following three years she lead a global analysis and advocacy team whose goal was to guarantee that appropriate medicines, vaccines and diagnostics are developed, available, affordable and adapted to people’s needs.[3]
Views[edit]
According to Torreele, the crisis of access to medicines is no longer one of only poor people in developing countries, but truly a global one.[4]
Torreele has written critical articles about pharmaceutical company's perceived deficient patent-driven model for pharmaceutical innovation[5][6] and poor governmental decisions resulting in highly-priced medicines.
In 2021, she spoke about the correlations between inequity and access COVID-19 vaccines across the world.[7]
Publications[edit]
She is the author or co-author of several journal articles and academic working papers, and also been active in a blogging, mainstream media[8] and in Twitter on the topic of access to medicines.[9]
References[edit]
- ↑ UCL (2020-10-20). "Els Torreele". UCL Institute for Innovation and Public Purpose. Retrieved 2022-01-13.
- ↑ "Access Campaign 20 years on | MSF". Médecins Sans Frontières (MSF) International. Retrieved 2022-01-13.
- ↑ UCL (2020-10-20). "Els Torreele". UCL Institute for Innovation and Public Purpose. Retrieved 2022-01-13.
- ↑ "Letter from the Director: 20 Years On, the Access-to-Medicines Battle is Going Global". Médecins Sans Frontières Access Campaign. Retrieved 2022-01-13.
- ↑ "Els Torreele". OPEN SOURCE PHARMA. Retrieved 2022-01-13.
- ↑ "Why We Shouldn't Rely on Patents to Encourage Medical Innovation". www.opensocietyfoundations.org. Retrieved 2022-01-13.
- ↑ Boston, 677 Huntington Avenue; Ma 02115 +1495‑1000 (2021-06-16). "PERSPECTIVE We Cannot Win the Access to Medicines Struggle Using the Same Thinking That Causes the Chronic Access Crisis". Health and Human Rights Journal. Retrieved 2022-01-13.
- ↑ UCL (2020-10-20). "Els Torreele". UCL Institute for Innovation and Public Purpose. Retrieved 2022-01-13.
- ↑ "Els Torreele". OPEN SOURCE PHARMA. Retrieved 2022-01-13.
This article "Els Torreele" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:Els Torreele. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.
